BLFS Stock Analysis: Buy, Sell, or Hold?
BLFS - BioLife Solutions Inc.
$19.51
0.22 (1.14%)
▲
5d:
-0.71%
30d:
-5.61%
90d:
-19.31%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
BLFS is down 7.6% this week, but smart money is accumulating calls. Top strike: $20 2026-04-17 with 3 OI. Call ratio: 100% View Scanner →
Strength: 8.8/10
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BLFS trading at deep discount. Market pricing in -20.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BLFS trading at deep discount. Market pricing in -20.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.12
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$8.77
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $19.51, which is considered fair relative to its 30-day fair value range of $18.50 to $21.62. From a valuation perspective, the stock is trading at a discount (Forward PE: 67.3) compared to its historical average (134.0). Remarkably, the market is currently pricing in an annual earnings decline of 20.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLFS is in a strong downtrend. Immediate support is located at $17.89, while resistance sits at $20.47.
Market Sentiment: BLFS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.40 (+66.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLFS is in a strong downtrend. Immediate support is located at $17.89, while resistance sits at $20.47.
Market Sentiment: BLFS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.40 (+66.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$18.50 -
$21.62
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 66.1% below Wall St target ($32.40)
Fair Price Analysis
30-Day Fair Range
$18.50 -
$21.62
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$17.89
Resistance Level
$20.47
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
67.28
Wall Street Target
$32.40
(+66.1%)
Revenue Growth (YoY)
63.9%
Earnings Growth (YoY)
-13.9%
Profit Margin
-4.8%
Valuation Discount vs History
-20.5% cheaper
PE vs Historical
67.3 vs 134.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-20.5%
(market-implied from PE analysis)
1-Year Target
$17.56
(-10%)
2-Year Target
$15.80
(-19%)
3-Year Target
$14.22
(-27%)
3-Yr Target (if PE normalizes)
(PE: 67→134)
$28.33
(+45%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 67.3, Growth: 114.8%)
$65.85
(+238%)
Base:
(SPY PE: 20.6, Growth: 114.8%)
$20.13
(+3%)
Bear:
(PE: 17.5, Growth: 114.8%)
$17.11
(-12%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 67.3 to 134.0
Stabilization Target:
$38.86
(+99.2%)
PE Expansion Potential:
+99.2%
Share & Embed Analysis
Last updated: April 02, 2026 6:47 PM ET
Data refreshes hourly during market hours. Next update: 7:47 PM
Data refreshes hourly during market hours. Next update: 7:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Karen A Foster
SELL
500 shares
2026-03-09
Karen A Foster
SELL
96923 shares
2026-03-05
Aby J Mathew
SELL
529 shares
2026-03-03
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 60 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 61 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 65 BUY |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
